228 related articles for article (PubMed ID: 34254425)
1. Evaluation of skin dose and skin toxicity in patients undergoing intraoperative radiotherapy for early breast cancer.
Wong JHD; Zaili Z; Abdul Malik R; Bustam AZ; Saad M; Jamaris S; Mosiun JA; Mohd Taib NA; Ung NM; See MH
J Appl Clin Med Phys; 2021 Aug; 22(8):139-147. PubMed ID: 34254425
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.
Kraus-Tiefenbacher U; Scheda A; Steil V; Hermann B; Kehrer T; Bauer L; Melchert F; Wenz F
Tumori; 2005; 91(4):339-45. PubMed ID: 16277101
[TBL] [Abstract][Full Text] [Related]
3. Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays?
Aziz MH; Schneider F; Clausen S; Blank E; Herskind C; Afzal M; Wenz F
Radiat Oncol; 2011 Dec; 6():174. PubMed ID: 22176703
[TBL] [Abstract][Full Text] [Related]
4. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer.
Wenz F; Welzel G; Keller A; Blank E; Vorodi F; Herskind C; Tomé O; Sütterlin M; Kraus-Tiefenbacher U
Breast; 2008 Dec; 17(6):617-22. PubMed ID: 18650091
[TBL] [Abstract][Full Text] [Related]
5. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients.
Reitsamer R; Peintinger F; Sedlmayer F; Kopp M; Menzel C; Cimpoca W; Glueck S; Rahim H; Kopp P; Deutschmann H; Merz F; Brandis M; Kogelnik H
Eur J Cancer; 2002 Aug; 38(12):1607-10. PubMed ID: 12142049
[TBL] [Abstract][Full Text] [Related]
7. [Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand].
Gatzemeier W; Orecchia R; Gatti G; Intra M; Veronesi U
Strahlenther Onkol; 2001 Jul; 177(7):330-7. PubMed ID: 11505618
[TBL] [Abstract][Full Text] [Related]
8. Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam
Key S; Miglierini P; Dupré PF; Guilbert S; Lucia AS; Abgral R; Conan-Charlet V; Uguen A; Pradier O; Schick U
Ann Surg Oncol; 2017 Sep; 24(9):2547-2555. PubMed ID: 28608120
[TBL] [Abstract][Full Text] [Related]
9. Breast-conserving surgery with intra-operative radiotherapy: the right approach for the 21st century?
Tobias JS; Vaidya JS; Keshtgar M; Douek M; Metaxas M; Stacey C; Sainsbury R; D'Souza D; Baum M
Clin Oncol (R Coll Radiol); 2006 Apr; 18(3):220-8. PubMed ID: 16605053
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Schoeber C; Schaefer J; Steil V; Wenz F
BMC Cancer; 2007 Sep; 7():178. PubMed ID: 17854511
[TBL] [Abstract][Full Text] [Related]
11. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach.
Wenz F; Welzel G; Blank E; Hermann B; Steil V; Sütterlin M; Kraus-Tiefenbacher U
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1309-14. PubMed ID: 20100643
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of local control and late radiation toxicity after intraoperative radiation therapy boost for early breast cancer.
Chang DW; te Marvelde L; Chua BH
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):73-9. PubMed ID: 24331652
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
[TBL] [Abstract][Full Text] [Related]
15. A prospective phase I comparison of toxicity and cosmesis outcomes of single-fraction IORT and hypofractionated radiotherapy with IORT boost in early-stage breast cancer.
Bhandari T; Babaran W; Forouzannia A; Williams V; Harness J; Carpenter M; Gobran M; Khanijou R; Wagman B; Ash R; Wagman LD
Brachytherapy; 2017; 16(6):1232-1238.e2. PubMed ID: 29032999
[TBL] [Abstract][Full Text] [Related]
16. Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy.
Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Liedtke C; Bulsara M; Vaidya JS
Strahlenther Onkol; 2017 Jan; 193(1):62-69. PubMed ID: 27858093
[TBL] [Abstract][Full Text] [Related]
17. Comparison of IORT (Radical and Boost Dose) and EBRT in Terms of Disease-Free Survival and Overall Survival according to Demographic, Pathologic, and Biological Factors in Patients with Breast Cancer.
Hashemi S; Javadi S; Akbari ME; Mirzaei H; Mahdavi SR
Int J Surg Oncol; 2021; 2021():2476527. PubMed ID: 33953982
[TBL] [Abstract][Full Text] [Related]
18. In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost.
Lee JJB; Choi J; Ahn SG; Jeong J; Lee IJ; Park K; Kim K; Kim JW
Radiat Oncol J; 2017 Jun; 35(2):121-128. PubMed ID: 28712278
[TBL] [Abstract][Full Text] [Related]
19. IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.
Ciabattoni A; Gregucci F; Fastner G; Cavuto S; Spera A; Drago S; Ziegler I; Mirri MA; Consorti R; Sedlmayer F
Breast Cancer Res; 2021 Apr; 23(1):46. PubMed ID: 33849606
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
